Works matching IS 21641153 AND DT 2023 AND VI 13

Results: 60

Management of Iron Infusion Reactions.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 6, p. 323

By:

Laza, Raluca;
Keisler, Meredith;
Handy, Victoria;
Dickens, Andrea

Publication type:

Article

Hematopoietic Stem-Cell Transplantation and Drug Considerations in Transgender Patients.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 6, p. 313

By:

Barthelmess, Erin Kate;
Perreault, Sarah;
Sabus, Ashley;
Topal, Jeffrey E.

Publication type:

Article

Real-World Efficacy and Safety of Tixagevimab Plus Cilgavimab in Patients with Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 6, p. 302

By:

Tong, Anhthy;
Ashouri, Karam;
Cai, Yijun;
Mohrbacher, Ann;
Hernandez, Eduardo Fernandez;
Shi, Samantha;
Yaghmour, George;
Ali, Amir

Publication type:

Article

Enhancing Pharmacovigilance Methodologies in Patients With Cancer at Infusion Centers.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 270

By:

Leonard, Joy;
Goldenhorn, Michael;
Keeys, Christopher;
Ali, Sabeen

Publication type:

Article

COVID-19 as a Primer for Drug-Induced Pneumonitis in Patients With Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 6, p. 285

By:

Yenamandra, Avani;
Greidinger, Alison;
Jenab-Wolcott, Jenia

Publication type:

Article

FDA Accelerated the Approval of Akeega, First and Only Dual-Action Tablet for Metastatic Prostate Cancer with BRCA Mutation.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 278
Publication type:: Article

Hepzato Kit FDA Approved as a Liver-Directed Treatment for Uveal Melanoma Hepatic Metastases.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 277
Publication type:: Article

FDA Granted Accelerated Approval to Elrexfio, a Bispecific BCMA-Directed CD3 T-Cell Engager, for Relapsed or Refractory MM.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 276
Publication type:: Article

Clinical Pharmacist–Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 6, p. 294

By:

Freml, Jared M.;
Byakina, Yuliya M.;
Thompson, Lisa A.;
Ekinci, Ekim;
Knudsen, Jasen K.;
De Silva, Chamath R.;
Boyle, Soames F.;
Delate, Thomas

Publication type:

Article

Clinical Role of Oncology Pharmacy Specialists in Oral Oncolytic Management in the Outpatient Hematology Clinic Setting.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 264

By:

Davenport, Lilia;
Tadros, Monica;
Al Sagheer, Tiba;
Roy, Sharmeen;
Rubens, Muni;
Ramos Morales, Alga;
Shwin, Moe

Publication type:

Article

Clinical, Laboratory, and Genetic Profiles and Outcomes of Patients With aHUS and Restrictive Use of Eculizumab: A Single-Center Experience.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 256

By:

Amisha, Fnu;
Konda, Manojna;
Malik, Paras;
Fugere, Brad;
Roy, Arya Mariam;
Sasapu, Appalanaidu

Publication type:

Article

Tolerance of Oral Targeted Agents in Patients With Advanced or Metastatic RCC With and Without Renal Impairment.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 246

By:

Mayer, Bradley;
Carroll, Emma;
Rhoades, Melissa;
Zook, Felicia

Publication type:

Article

Evaluation of Same-Day Versus Next-Day Administration of Pegfilgrastim in Patients With Breast Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 241

By:

Weise Jr., Michael P.;
Cascone, Vincent;
Huong Tran;
Martin, Grace;
Mahmoudjafari, Zahra;
Guangyi Gao;
Khan, Qamar

Publication type:

Article

Are We Ready for Same-Day Pegfilgrastim and Chemotherapy?

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 5, p. 239

By:

Ignoffo, Robert J.

Publication type:

Article

Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 223
Publication type:: Article

Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 222
Publication type:: Article

Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 221
Publication type:: Article

Vanflyta Now Approved for Newly Diagnosed FLT3-ITD--Positive AML.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 220
Publication type:: Article

FDA Accelerated the Approval of Columvi for Selected Relapsed or Refractory Large B-Cell Lymphomas.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 220
Publication type:: Article

Impact of Pharmacist-Led Oral Chemotherapy Telehealth Clinic at a Community Cancer Center Using the TAMER Model.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 211

By:

Tamer, Diana;
Schieber, Timothy;
Wodtke, Jake;
Zantout, Samira

Publication type:

Article

A Review of Clinical Data Among Biosimilars: Just How Similar Are They?

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 199

By:

Marjoncu, Dennis

Publication type:

Article

Duration of Response to PARP Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients With Germline or Somatic HRD.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 192

By:

Adolphsen, Jordanne;
Monson, Taylor;
Martin, Grace;
Mahmoudjafari, Zahra;
Meier, Richard;
Shae, Whitney;
Koestler, Devin C.;
Bohnenkamp, Colleen

Publication type:

Article

Effects of Levofloxacin Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia, Relapsed Acute Lymphoblastic Leukemia, or Patients Undergoing Hematopoietic Stem Cell Transplant.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 185

By:

Linden, Livia;
Timaeus, Sarah;
Gillon, Jessica;
Gulley, Savannah

Publication type:

Article

Effects of Vascular Endothelial Growth Factor Inhibitor--Induced Proteinuria on Treatment Course and Outcomes: Retrospective Analysis and Review of the Literature.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 178

By:

Murdock, Joshua L.;
Duco, Marissa R.;
Reeves, David J.

Publication type:

Article

New Oncology Drugs, New Indications, and New Formulations Approved by the FDA.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 167
Publication type:: Article

Preclinical and Early Clinical Data Show Promising Antitumor Activity With the HER2 Inhibitor ZN-1041 in Patients With Breast Cancer and Brain Metastases.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 166
Publication type:: Article

Dalpiciclib Plus Pyrotinib and Endocrine Therapy Shows Promising Antitumor Activity in ER-Positive, HER2-Positive Metastatic Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 165
Publication type:: Article

Phase 1b/2 Trial of Ribociclib, Tucatinib, and Trastuzumab to Find Chemotherapy-Free Treatment Combination Regimens for HER2-Positive Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 164
Publication type:: Article

Strong Antitumor Activity With Neoadjuvant Intratumoral Dendritic Cell Vaccine Therapy Plus Paclitaxel, Trastuzumab, and Pertuzumab in HER2-Positive Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 163
Publication type:: Article

Anti-HER2/HER3 αDC1 Vaccines Plus Pembrolizumab for Brain Metastases in Patients With Triple-Negative or HER2-Positive Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 162
Publication type:: Article

Neratinib Plus Trastuzumab Emtansine in Patients With HER2-Positive Breast Cancer and Molecular Residual Disease.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 161
Publication type:: Article

Dalpiciclib Plus Pyrotinib Prolongs Survival in Patients With HER2-Positive Advanced Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 160
Publication type:: Article

Inetetamab Plus Camrelizumab and Utidelone Safe and Effective in Patients With HER2-Positive Metastatic Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 159
Publication type:: Article

Prolonged Effectiveness With Tucatinib Plus Trastuzumab and Capecitabine in HER2-Positive Metastatic Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 158
Publication type:: Article

Zanidatamab Plus Docetaxel Shows Promising Antitumor Activity in Advanced HER2-Positive Breast Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 157
Publication type:: Article

Successful Extended At-Home Olaparib Desensitization After a Hypersensitivity Reaction: A Case Report.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 153

By:

Jia, Lily Y.;
Sendrowski, Brendan;
Lax, Timothy;
Shea, Meghan

Publication type:

Article

Clinical and Financial Impacts of an Ambulatory Oncology Pharmacist-Based Intravenous Chemotherapy Education and Follow-Up Program.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 146

By:

Lee, Grant W.;
Chundamala, Joseen J.;
Monahan, Kerri L.;
Cho, Judy J.;
Berry, Lydia J.;
Cambareri, Christine G.

Publication type:

Article

Stopping Oral Chemotherapy Agents With a High Bleeding Risk Before and After Minor Surgical Procedures.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 140

By:

Marjoncu, Dennis;
Carmichael, Jenna;
Andrick, Benjamin J.;
Oxenberg, Jacqueline

Publication type:

Article

Retrospective Evaluation of Initial Empiric Double Coverage With Tobramycin in Adult Patients With Febrile Neutropenia.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 133

By:

Clemmons, Amber B.;
Shelley, Rachel;
Chittavong, Vayou;
Huimin Hu;
Xianyan Chen;
Eudy, Joshua;
Chao, Andrew;
Anderson, Daniel T.

Publication type:

Article

Incidence of Infusion-Related Reactions With Pertuzumab and Ado-Trastuzumab Emtansine: A Retrospective Study.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 128

By:

Smith, Sara Moran

Publication type:

Article

To the Editor.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 126

By:

Hamadeh, Issam S.;
Atrash, Shebli

Publication type:

Article

JHOP Editorial Board Member, Readers, and Author Interact: Optimizing the Administration of Daratumumab.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 3, p. 125

By:

Soefje, Scott A.

Publication type:

Article

ASCO GI CANCERS 2023 HIGHLIGHTS.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 112
Publication type:: Article

New Oncology Drugs, New Indications, and New Formulations Approved by the FDA.

Published in:: Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 107
Publication type:: Article

Novel Use of Ravulizumab in Transplant-Associated Thrombotic Microangiopathy: Case Report.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 102

By:

Gonzales, Manuel R.;
White, Jason C.;
Davidow, Kimberly A.;
Mangum, David S.;
Grimm, Kailey E.

Publication type:

Article

Palbociclib-Induced Hepatotoxicity in a Patient with Metastatic Breast Cancer: A Case Report.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 96

By:

Hutchinson, Jennifer A.;
Green, Jenna;
Jacques, Christopher;
Ju Hee Kim;
Haggett, Dana;
Straw, Olivia;
Shin, Jennifer

Publication type:

Article

Oral Chemotherapy Program Metrics: Results of a National Survey.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 85

By:

Fahey, Olivia G.;
Barbour, Sally Y.;
Golf, Mary A.;
Malard Johnson, Darcy K.;
Morgan, Rachael M.;
Rhoades, Melissa J.;
Taucher, Kate D.;
Valgus, John M.

Publication type:

Article

Incidence and Severity of Neuropathy with Concurrent Use of Voriconazole and Vincristine in Pediatric Patients with Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 77

By:

Sabus, Ashley;
Merrow, Mya;
Burke, Ellen;
Kordas, Gordon;
Williams, Megan;
Larson, Maria;
Eisenman, Kristen

Publication type:

Article

Evaluation of Outcomes in Patients Who Received Bevacizumab for the Treatment of Brain Radionecrosis.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 72

By:

Below, Jameshia A.;
Khan, Alina;
Brahim, Amanda;
Raez, Luis E.;
Izquierdo, Paola

Publication type:

Article

Safety of SC Daratumumab in the Treatment of Plasma-Cell Disorders: A Single-Center Experience.

Published in:

Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 2, p. 65

By:

Jung Kye;
Patel, Samit;
Seyer, Maggie;
Eun-Jeong Kim;
Hewitt, Rhonda;
Liedtke, Michaela;
Iberri, David

Publication type:

Article